Drugs with this side effect
- 1,25(OH)2D3
- 2-hydroxysuccinaldehyde: 10%
- 5-ASA: very rare, postmarketing, 3% - 8%
- 5-FU: 0% - 1.57%
- 5-aza-2'-deoxycytidine: 1.23% - 9.09%
- 5-azacytidine: common, 2.17% - 15.9%
- A77 1726: 3% - 3.35%
- Azarga
- BCNU: 1%
- Benicar-HCT
- CAS 76095-16-4
- CAS 76420-72-9: postmarketing
- CGP 19835A: very common, 31%
- Cancidas: 0% - 3.1%
- EACA
- EDTA
- Enfuvirtide: 1.2% - 7%
- FAMP
- Fe(III: postmarketing, 0% - 3.6%
- Forteo: uncommon
- Ge-132: 1%
- Goserelin: 3% - 11%
- Histrelin
- Humalog: 5.81% - 7.41%
- ICI 182,780: postmarketing
- Implanon: postmarketing
- Insulin
- K779: 3% - 75%
- L-Dmp
- LY146032: postmarketing, uncommon, 1%
- Lantus
- Leuprorelin: postmarketing, 3% - 9%
- Lisinopril: postmarketing
- Lovaza
- MK-462: postmarketing
- Metrodin
- Nafarelin: 10%
- Nuvocid
- Octreotide
- Oestrogen: 0.157% - 11.8%
- Optison
- PGE2
- Promacta: 5.93%
- SOM230: 5% - 12.2%
- SU5416: 14%
- Saxagliptin
- Signifor: 5% - 12.2%
- Supremon: 1.79%
- TMC207
- TMC435: 16.1%
- Triptorelin: 1.1%
- UDCA: postmarketing, 5.8% - 5.81%
- VACV: 0.5% - 57%
- abacavir: 13%
- abacavir-lamivudine
- abiraterone: 2.3% - 3%
- acamprosate
- acebutolol: 0% - 4%
- acipimox
- acitretin: postmarketing
- actinomycin D
- acyclovir
- adefovir dipivoxil
- alendronate: postmarketing, 0% - 1.1%
- allopurinol: postmarketing
- almotriptan: postmarketing, infrequent
- alosetron: rare
- alprazolam: 1.5%
- ambrisentan
- aminoglutethimide
- amlodipine
- amlodipine besylate
- amphotericin B
- amprenavir
- anagrelide: 1-5%
- anastrozole: postmarketing, 5.17% - 5-36%
- anthracycline: 0% - 12%
- apraclonidine
- aprepitant
- aripiprazole: 1% - 4%
- arsenic
- arsenic trioxide: common
- articaine
- atazanavir: postmarketing, uncommon
- atomoxetine: 3%
- atorvastatin: postmarketing, 0% - 5.6%
- atovaquone
- avanafil
- axitinib: 7%
- azathioprine
- azelastine
- azithromycin
- aztreonam
- baclofen: common
- balsalazide: 1% - 1.16%
- benazepril
- benazeprilat
- bepridil
- betaxolol: 3.2% - 3.7%
- bexarotene: common, 10%
- bezafibrate
- bicalutamide
- bisoprolol: 2.1%
- bleomycin hydrochloride
- boceprevir: very common, 24%
- bortezomib: 0% - 14%
- bosutinib
- brimonidine
- brinzolamide
- bromcresol green: 0% - 3%
- budesonide
- buprenorphine
- bupropion: postmarketing, 1.6% - 6%
- buspirone
- busulfan
- cabazitaxel
- candesartan
- candesartan cilexetil: postmarketing
- capecitabine: 2% - 25%
- captopril: postmarketing
- carbamazepine: very rare, rare
- carbimazole
- carboplatin
- carboprost
- carnitine
- carvedilol: 3.4%
- cefaclor
- cefditoren
- cefpodoxime
- celecoxib
- cerivastatin: 2.5%
- cetirizine: postmarketing
- cevimeline
- chlorhexidine
- cidofovir
- cilazapril
- cilostazol: 2% - 3%
- cimetidine
- cinacalcet: postmarketing, common, 15%
- ciprofloxacin: postmarketing, rare
- cisplatin
- citalopram: infrequent, uncommon, frequent, 1.9% - 2%
- cladribine: common, 6% - 7%
- clarithromycin: postmarketing
- clobazam
- clofarabine: common
- clomiphene citrate: postmarketing
- clomipramine: 13%
- clonazepam: 1%
- clopidogrel: very rare, postmarketing
- clozapine: 1%
- cobicistat: uncommon
- colchicine: postmarketing
- colesevelam: 2% - 2.11%
- conjugated estrogens
- copolymer 1
- cortisol
- cyanocobalamin
- cyclobenzaprine: postmarketing
- cyclophosphamide: postmarketing
- cytarabine
- dabrafenib: very common, 0% - 24%
- dacarbazine
- dantrolene
- darunavir
- dasatinib: common, 0% - 13%
- deferoxamine: very common
- delamanid
- delavirdine
- delta 9-THC
- demethyl
- deprenyl: frequent, 3%
- desflurane: postmarketing
- desloratadine: 2.1%
- desmopressin
- dexamethasone
- dexamethasone sodium phosphate
- dexrazoxane
- diazepam
- diclofenac: postmarketing, 0% - 3%
- dicloxacillin
- didanosine: postmarketing
- diethylpropion
- dihydroergotamine: infrequent
- diltiazem: postmarketing, 0% - 2.31%
- dipyridamole: 0.9%
- docetaxel: 0% - 50.9%
- dolasetron
- donepezil: infrequent
- doxazosin: 0% - 1.4%
- doxepin: infrequent
- doxercalciferol
- doxorubicin: common
- doxycycline: 0.939% - 6.4%
- doxycycline hyclate: 0.939%
- duloxetine: common, 1% - 4%
- efavirenz: postmarketing
- eletriptan: infrequent
- eltrombopag: 5%
- emtricitabine
- entacapone
- eplerenone
- eprosartan
- ergotamine
- eribulin: 1% - 22%
- erlotinib
- eslicarbazepine acetate
- esomeprazole magnesium: postmarketing
- estazolam: infrequent
- estradiol: postmarketing, 1.72% - 5.62%
- etodolac: postmarketing
- everolimus: common, 1.66% - 7.17%
- exemestane: very common, 5.5% - 2-33%
- ezetimibe: postmarketing, 0.5% - 3.2%
- famciclovir: very rare, postmarketing
- famotidine
- febuxostat
- felbamate: 2.6%
- felodipine
- fenofibrate: postmarketing, uncommon, 0.629% - 6.12%
- fenofibric acid: postmarketing, 3.07% - 6.12%
- fentanyl
- ferumoxytol: postmarketing
- fexofenadine: 2.6%
- flecainide
- flucloxacillin: very rare
- fluconazole: postmarketing, uncommon
- fludarabine: 4% - 16%
- fludrocortisone
- flunisolide
- fluoxetine: 3.3% - 4.7%
- flurbiprofen
- fluticasone
- fluvastatin: postmarketing, rare, 1.5% - 5%
- fluvoxamine: infrequent, uncommon, 2% - 5%
- formoterol: uncommon
- fosamprenavir
- foscarnet
- fosfomycin
- fosfomycin trometamol
- fosinopril
- fosinoprilat
- fosphenytoin: infrequent
- frovatriptan: infrequent
- gabapentin: infrequent, 1.9% - 2%
- gadobenate dimeglumine
- gadodiamide
- gadolinium
- gadoversetamide
- galantamine
- ganciclovir
- gatifloxacin
- gemcitabine: very common, 0% - 33%
- gemfibrozil
- gemifloxacin
- glibenclamide
- gliclazide: 1.5% - 2.3%
- glipizide
- glutamine: 0% - 12.5%
- guanfacine: postmarketing
- halofantrine: 1.3%
- hepatitis B vaccines: rare, uncommon
- hetastarch: postmarketing
- histamine
- hydralazine: common
- hydrochlorothiazide
- hydrocodone
- hydromorphone
- hydroxybutyrate
- ibandronate: postmarketing, 0.8% - 6%
- ibuprofen
- icodextrin
- ifosfamide: postmarketing
- iloperidone
- imatinib: very common, 0% - 38.8%
- imiquimod: common, 0% - 2%
- indacaterol: uncommon
- indapamide
- indinavir
- insulin detemir: 0.7% - 1.4%
- iopamidol
- ipratropium bromide
- irbesartan: postmarketing, rare
- irbesartan-hydrochlorothiazide
- iron sucrose
- isomannide
- isosorbide-5-mononitrate: very rare
- itraconazole: postmarketing, 1%
- ivacaftor
- ivermectin
- ixabepilone: 5% - 49%
- ketoconazole
- ketoprofen
- ketorolac: postmarketing
- ketorolac tromethamine: postmarketing
- lamivudine: common, 2% - 11.6%
- lamotrigine: 0.9% - 2.8%
- lanreotide
- lansoprazole
- lapatinib: very common, 0% - 10%
- leflunomide
- lenalidomide: postmarketing, common
- lercanidipine: rare
- letrozole: common, 0.312% - 12-21%
- leuprorelin acetate
- levetiracetam: common
- levonorgestrel
- linagliptin
- lomefloxacin
- lomitapide
- loratadine
- lormetazepam
- losartan
- lovastatin: postmarketing, 1.8% - 3%
- lubiprostone
- lurasidone
- maraviroc: 0.5% - 3%
- medroxyprogesterone acetate
- mefloquine: postmarketing
- meloxicam: 0% - 1.3%
- melphalan: very common
- memantine
- mesna: postmarketing
- metaproterenol
- metformin
- methimazole
- methotrexate: 1-10%
- methyldopa
- methylphenidate: postmarketing
- methylprednisolone
- methylprednisolone sodium succinate
- methysergide
- metipranolol
- mianserin
- mifepristone: 14%
- minocycline: 0.8% - 1.9%
- mipomersen
- mirtazapine: postmarketing, 1.99% - 2%
- misoprostol: postmarketing
- mitoxantrone: 5%
- moclobemide
- modafinil
- moexiprilat: 1.34%
- mometasone: 2% - 3%
- mometasone furoate: 2% - 3%
- montelukast: postmarketing
- moxifloxacin
- mycophenolate mofetil: 9.3% - 12.5%
- mycophenolic acid
- nabilone
- nafcillin
- nalmefene
- naltrexone: postmarketing
- naproxen: postmarketing
- naratriptan: infrequent
- nefazodone
- nelarabine: 0% - 13%
- nelfinavir
- nevirapine: postmarketing, common, 0.2% - 1.2%
- niacin: postmarketing
- nicardipine: 0.192%
- nicorandil: common
- nicotine: 3% - 3.1%
- nifedipine: postmarketing
- nilotinib: 1% - 12%
- nimodipine: 0%
- nisoldipine
- nitazoxanide
- nitrofurantoin
- nizatidine: 1.7%
- norfloxacin: postmarketing
- nystatin
- ofloxacin
- olanzapine
- olmesartan: postmarketing, uncommon
- olmesartan medoxomil
- olsalazine: postmarketing
- omeprazole: postmarketing, rare
- orlistat: uncommon, 4.2%
- oseltamivir
- oxacillin
- oxaliplatin: 0% - 2%
- oxcarbazepine: very rare
- oxycodone
- paclitaxel: 1% - 44%
- paliperidone: 1% - 4%
- palonosetron
- pamidronate: postmarketing, common, 0% - 26.4%
- pantoprazole: very rare, postmarketing
- paricalcitol
- paroxetine: rare, common, 5%
- pazopanib: 0% - 23%
- pemetrexed: 0% - 20%
- penicillin
- pentamidine
- pentosan polysulfate
- pentostatin: 11% - 36%
- pentoxifylline
- perampanel: 1% - 3%
- pergolide: frequent, 1.1%
- perindopril
- perindopril erbumine: postmarketing
- perindoprilat: postmarketing
- phenobarbital
- phenytoin: infrequent
- pilocarpine
- pimozide: 2.78%
- pindolol: 8% - 10%
- pioglitazone: 2.8% - 5.4%
- piperacillin
- pirfenidone
- pitavastatin: 1.9% - 3.1%
- pizotifen
- ponatinib: 0% - 22%
- posaconazole
- pramipexole: 1.6%
- pravastatin: 0.6% - 2.7%
- praziquantel: postmarketing
- prednisolone phosphate
- prednisone
- pregabalin: frequent
- procainamide
- procarbazine
- progesterone
- propafenone
- propofol
- propylthiouracil
- prostacyclin: 31% - 44%
- pyrazinamide
- pyridostigmine: 2%
- quetiapine: 2% - 5%
- quinapril: 1.5%
- quinaprilat: 1.5%
- quinidine
- rabeprazole: postmarketing
- raloxifene: 7.7%
- raltegravir
- ramelteon: 2%
- ramipril
- ramiprilat
- ranitidine
- rapamycin
- regadenoson: postmarketing
- rescinnamine
- retinoic acid: postmarketing, 14%
- ribavirin: very common, 17% - 64%
- rifabutin: 2%
- rifapentine
- rifaximin
- riluzole
- risedronate: postmarketing, 4.6% - 6.2%
- risperidone: infrequent, 0% - 5%
- ritonavir: 0.8% - 2.4%
- rivastigmine: infrequent, frequent
- rizatriptan: infrequent
- rofecoxib
- roflumilast
- ropinirole: frequent
- ropivacaine: 0.1% - 1%
- rosiglitazone
- rosuvastatin: postmarketing, common, 1.9% - 12.7%
- salbutamol: postmarketing, 0% - 3.3%
- salmeterol
- salmon calcitonin acetate
- saquinavir
- sertraline: postmarketing, frequent
- sibutramine
- sildenafil: postmarketing, uncommon, 3% - 14%
- simvastatin: postmarketing, 0.1% - 3.7%
- sitagliptin: postmarketing
- sodium cromoglycate
- sodium ferric gluconate
- sofosbuvir: common, very common, 0% - 16%
- sorafenib: postmarketing, common
- sotalol: postmarketing
- sparfloxacin
- stavudine: postmarketing, uncommon
- strontium ranelate: postmarketing
- succinylcholine
- sulfamethoxazole
- sulindac
- sumatriptan: frequent, 0.1% - 2%
- sunitinib
- tacrolimus: postmarketing, 0% - 3%
- tadalafil: 1% - 14%
- tamoxifen: 5.17% - 5.79%
- tamsulosin: 1.7%
- tegaserod: 1%
- telavancin: uncommon
- telithromycin: postmarketing
- telmisartan: postmarketing, uncommon, common, 1.1%
- temozolomide: uncommon, common, 1% - 5.06%
- temsirolimus
- tenofovir: 3% - 4%
- tenofovir disoproxil fumarate: 3% - 4%
- terazosin
- terbinafine: postmarketing, very common
- terconazole: postmarketing
- tesamorelin: 0% - 5.5%
- testosterone: postmarketing
- testosterone enanthate: postmarketing
- testosterone propionate
- testosterone undecanoate
- thalidomide: 0% - 16.7%
- thiotepa
- thymidine: 2% - 3.19%
- tiagabine: 2% - 5%
- tibolone
- ticlopidine
- tigecycline
- tiludronate
- timolol
- tinidazole
- tiopronin
- tiotropium: 3% - 4%
- tipranavir: uncommon, 1.8%
- tobramycin
- tolcapone: frequent
- topiramate: postmarketing, 2% - 2.5%
- topotecan: 0% - 4%
- torasemide: 1.6%
- trabectedin
- tramadol: postmarketing, uncommon
- trametinib: 0% - 24%
- trandolapril: postmarketing, 4.7%
- trandolaprilat: 4.7%
- tranexamic acid
- trans 4-cyclohexyl-L-proline
- travoprost
- trazodone
- treprostinil
- triamcinolone: 2.5% - 3.3%
- triamcinolone acetonide
- trien
- trimethoprim: very rare
- trimethoprim-sulfamethoxazole: very rare
- trovafloxacin
- umeclidinium: 1%
- ustekinumab: common, 1%
- v 1784: postmarketing, common
- valdecoxib: 1.4% - 2.4%
- valproate
- valrubicin
- valsartan
- vardenafil
- varenicline: frequent
- vemurafenib: postmarketing, 0% - 24%
- venlafaxine
- verapamil: postmarketing
- vigabatrin: 3% - 5%
- vincristine
- vinflunine
- vinorelbine: postmarketing, 0% - 3%
- vismodegib
- voriconazole
- x M22
- zafirlukast: 1.6%
- zalcitabine
- zaleplon: frequent
- zanamivir: 3% - 8%
- ziconotide
- zidovudine: common, 8%
- zidovudine/lamivudine: 3.5% - 11.6%
- zileuton: 7%
- ziprasidone: frequent, 2%
- zoledronic acid: postmarketing, common, very common, 4% - 22.7%
- zolmitriptan: infrequent, 1% - 2%
- zolpidem: frequent, 1% - 7%
- zonisamide: infrequent
- zopiclone
- zuclopenthixol
|
Drugs with this indication
|
